Scribe Therapeutics Inc. (SCTX)

Scribe Therapeutics Inc. (SCTX) is a healthcare company (biotechnology) based in the United States. The share price is $15.59, up 1.40% on the day, which values the company at $295.14M. Price as of 17 Nov 2026, 17:35 UTC, from Yahoo Finance.

Key facts

Share price
$15.59+1.40% today
Market value
$295.14M
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Scribe Therapeutics Inc. in more detail

SCTX trades at -4.6× next year's expected earnings, 19.9× sales.

In its favour: More cash than debt. Worth checking: Altman Z in the distress zone; Weak Piotroski score.

2 of the superinvestors tracked here hold SCTX, including Cathie Wood (0.1% of the portfolio), Andrew Spokes (0.0% of the portfolio).

Superinvestors holding SCTX

2 of the investors tracked here report a position in their latest 13F filing.

Scribe Therapeutics Inc. (SCTX): questions and answers

What is Scribe Therapeutics Inc.'s market cap?

Scribe Therapeutics Inc. is valued at $295.14M at a share price of $15.59.

Does SCTX pay a dividend?

Scribe Therapeutics Inc. does not currently pay a regular dividend.

Which famous investors own SCTX?

In their latest quarterly filings, Cathie Wood (0.1% of the portfolio), Andrew Spokes (0.0% of the portfolio) hold SCTX. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Scribe Therapeutics Inc. (SCTX) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/SCTX

Underlying data: Yahoo Finance; company filings with the SEC.